1304 related articles for article (PubMed ID: 23247577)
41. Barrett's esophagus: a surgical disease.
Patti MG; Arcerito M; Feo CV; Worth S; De Pinto M; Gibbs VC; Gantert W; Tyrrell D; Ferrell LF; Way LW
J Gastrointest Surg; 1999; 3(4):397-403; discussion 403-4. PubMed ID: 10482692
[TBL] [Abstract][Full Text] [Related]
42. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A
Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546
[TBL] [Abstract][Full Text] [Related]
43. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
44. Epidemiology of the complications of gastroesophageal reflux disease.
Belhocine K; Galmiche JP
Dig Dis; 2009; 27(1):7-13. PubMed ID: 19439954
[TBL] [Abstract][Full Text] [Related]
45. Medical management of Barrett's esophagus.
Lee TJ; Kahrilas PJ
Gastrointest Endosc Clin N Am; 2003 Jul; 13(3):405-18. PubMed ID: 14629098
[TBL] [Abstract][Full Text] [Related]
46. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
47. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
[TBL] [Abstract][Full Text] [Related]
48. Reflux disease and Barrett's esophagus.
Haag S; Holtmann G
Endoscopy; 2003 Feb; 35(2):112-7. PubMed ID: 12561004
[TBL] [Abstract][Full Text] [Related]
49. A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure.
Wakelin DE; Al-Mutawa T; Wendel C; Green C; Garewal HS; Fass R
Gastrointest Endosc; 2003 Sep; 58(3):350-5. PubMed ID: 14528207
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for esophageal cancer development.
Falk GW
Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
[TBL] [Abstract][Full Text] [Related]
51. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
Lassen A; Hallas J; de Muckadell OB
Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
[TBL] [Abstract][Full Text] [Related]
52. Incidence of GERD, esophagitis, Barrett's esophagus, and esophageal adenocarcinoma after bariatric surgery.
Bevilacqua LA; Obeid NR; Yang J; Zhu C; Altieri MS; Spaniolas K; Pryor AD
Surg Obes Relat Dis; 2020 Nov; 16(11):1828-1836. PubMed ID: 32711954
[TBL] [Abstract][Full Text] [Related]
53. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus.
Gray MR; Donnelly RJ; Kingsnorth AN
Gut; 1993 Jun; 34(6):727-31. PubMed ID: 8314502
[TBL] [Abstract][Full Text] [Related]
54. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma.
Veugelers PJ; Porter GA; Guernsey DL; Casson AG
Dis Esophagus; 2006; 19(5):321-8. PubMed ID: 16984526
[TBL] [Abstract][Full Text] [Related]
55. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all.
Rajendra S; Kutty K; Karim N
Dig Dis Sci; 2004 Feb; 49(2):237-42. PubMed ID: 15104363
[TBL] [Abstract][Full Text] [Related]
56. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
Cook MB; Shaheen NJ; Anderson LA; Giffen C; Chow WH; Vaughan TL; Whiteman DC; Corley DA
Gastroenterology; 2012 Apr; 142(4):744-53. PubMed ID: 22245667
[TBL] [Abstract][Full Text] [Related]
57. Gastroesophageal reflux and cancer.
Turcotte S; Duranceau A
Thorac Surg Clin; 2005 Aug; 15(3):341-52. PubMed ID: 16104125
[TBL] [Abstract][Full Text] [Related]
58. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
Jankowski J; Hopwood D; Pringle R; Wormsley KG
Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
[TBL] [Abstract][Full Text] [Related]
59. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
[TBL] [Abstract][Full Text] [Related]
60. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.
Grotenhuis BA; van Lanschot JJ; Dinjens WN; Wijnhoven BP
Recent Results Cancer Res; 2010; 182():39-63. PubMed ID: 20676870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
